Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)-Reference-Cited by-同舟云学术

Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)

Published:1983-12 Issue:4 Volume:4 Page:261-271
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Gottfries Carl-Gerhard,Adolfsson Rolf,Aquilonius Sten-Magnus,Carlsson Avid,Eckernas Sven-Ake,Nordberg Agneta,Oreland Lars,Svennerholm Lars,Wiberg Åsa,Winblad Bengt

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference71 articles.

1. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature;Adolfsson;J Neural Transm,1979

2. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type;Adolfsson;Life Sci,1980

3. Prevalence of dementia disorders in institutionalized Swedish old people;Adolfsson,1981

4. Biochemical changes in central catecholaminergic neurons of the senescent rats;Algeri,1978

5. A comparison between healthy volunteers and patients with multiple sclerosis;Andersen;Acta Neurol Scand,1981

Cited by 297 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid and positron-emission tomography biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis;Brain Communications;2023

2. Dopaminergic Nerve Terminal Imaging Across the Spectrum of Aging, Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder, Parkinsonism and Dementia;Molecular Imaging of Neurodegenerative Disorders;2023

3. A PAM of the α1A-Adrenergic receptor rescues biomarker, long-term potentiation, and cognitive deficits in Alzheimer’s disease mouse models without effects on blood pressure;Current Research in Pharmacology and Drug Discovery;2023

4. In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases;Alzheimer's Research & Therapy;2021-11-12

5. CSF and PET biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis;2021-10-03